iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · Real-Time Price · USD
6.67
-0.04 (-0.52%)
At close: May 9, 2025, 4:00 PM
6.73
+0.07 (0.98%)
After-hours: May 9, 2025, 7:34 PM EDT
iTeos Therapeutics Market Cap
iTeos Therapeutics has a market cap or net worth of $255.09 million as of May 9, 2025. Its market cap has decreased by -32.67% in one year.
Market Cap
255.09M
Enterprise Value
-260.22M
1-Year Change
-32.67%
Ranking
Category
Stock Price
$6.67
Market Cap Chart
Since July 24, 2020, iTeos Therapeutics's market cap has decreased from $636.93M to $255.09M, a decrease of -59.95%. That is a compound annual growth rate of -17.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 255.09M | -9.08% |
| Dec 31, 2024 | 280.58M | -28.40% |
| Dec 29, 2023 | 391.85M | -43.60% |
| Dec 30, 2022 | 694.79M | -57.70% |
| Dec 31, 2021 | 1.64B | 38.57% |
| Dec 31, 2020 | 1.19B | 86.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.54B |
| Johnson & Johnson | 375.73B |
| UnitedHealth Group | 353.03B |
| AbbVie | 328.80B |
| Novo Nordisk | 287.72B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |